Greencamp

FEBRUARY 17, 2019

Usually, the diagnosis involves excluding conditions like parasitic infections, lactose intolerance tests and small intestinal bacterial overgrowth which all produce symptoms like IBS. Constant gut symptoms often lead to the development of other conditions like anxiety , depression , migraines , sleeping problems and fatigue.

Digestion 96

Digestion Research and Development Marijuana Cannabinoids 96

Greencamp

AUGUST 16, 2018

The available body of evidence suggests that besides the lessening of symptoms, cannabis is also capable of slowing down the overall rate of progression of this horrible condition. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Greencamp

FEBRUARY 2, 2019

Examples include pneumonia, cancers, tuberculosis, chronic diarrhea, and inflammation-based conditions such as meningitis and encephalitis. Depending on what type of cell it is, but also the type of condition a person is struggling with, these factors determine the way how will a specific cell react to cannabinoids. 2016 ( 3 ).

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

The Cannigma

JANUARY 13, 2023

Migraines are a peculiarly painful condition. Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. Edibles won’t produce the same experience, but topicals may be able to help, too. A secondary headache is a symptom of another medical issue.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Spasticity from neurological conditions. Background. Conclusions. Cancer pain.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. September 2004. 30 (2): 187–96.(1998).

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73